Raphaël Durand

Axilum Robotics SAS develops and commercializes robotic solutions designed to assist medical professionals in the implementation of technical gestures. Its first project is a robot to assist psychiatrists and neurologists for Transcranial Magnetic Stimulation (TMS). The firm's project TMS is a painless, non invasive medical technique that applies high intensity magnetic impulses to cortex areas by placing a coil on the surface of the head. The company was founded by Bernard Bayle, Michel Berg, Michel de Mathelin, Romuald Ginhoux, Benjamin Maurin and Pierre Renaud in April 2011 and is headquartered in Strasbourg, France.

Part of Inner Mongolia Furui Medical Science Co., Ltd., Echosens North America, Inc. is a private company that manufactures FibroScan®, a non-invasive solution that accurately measures liver stiffness and liver steatosis for a comprehensive management of liver disease. The company is based in Waltham, MA. The company's agile 4 (FibroScan®-based score) is a test for the identification of cirrhosis in NAFLD patients combining LSM by VCTE™ with blood biomarkers (AST, ALT, platelets). The company is shaping the future of liver health and empowering medical professionals to manage liver health for simpler, faster, and better patient care. Jon S. Gingrich has been the CEO of the company since 2019.

Echosens SA engages in the manufacture of medical imaging equipment. It focuses on developing FibroScan. The company was founded by Laurent Sandrin and Sylvain Yon on June 20, 2001 and is headquartered in Paris, France.